Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Quaranta

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Virology|September 22, 2021
CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal RepeatsMichele Lai, Eyal Maori, Paola Quaranta, et al.
Cytotherapy|January 23, 2016
Human Wharton's jelly-derived mesenchymal stromal cells engineered to secrete Epstein-Barr virus interleukin-10 show enhanced immunosuppressive propertiesPaola Quaranta, Daniele Focosi, Marilena Di Iesu, et al.
Antiviral Research|April 12, 2017
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challengeNicola Clementi, Elena Criscuolo, Francesca Cappelletti, et al.
Diabetes Technology & Therapeutics|May 18, 2010
Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantationBiancamaria Longoni, Erzsebet Szilagyi, Paola Quaranta, et al.
PNAS Nexus|September 21, 2023
Severe acute respiratory syndrome coronavirus 2 infection leads to Tau pathological signature in neuronsCristina Di Primio, Paola Quaranta, Marianna Mignanelli, et al.
Journal of Medical Genetics|January 6, 2016
Gene editing of DNAH11 restores normal cilia motility in primary ciliary dyskinesiaMichele Lai, Massimo Pifferi, Andrew Bush, et al.
Viruses|May 28, 2022
Palmitoylethanolamide (PEA) Inhibits SARS-CoV-2 Entry by Interacting with S Protein and ACE-2 ReceptorRossella Fonnesu, Venkata Bala Sai Chaitanya Thunuguntla, Ganesh Kumar Veeramachaneni, et al.
Journal of Clinical Virology Plus|March 9, 2022
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibodyGiovanna Moscato, Paola Mazzetti, Ersilia Lucenteforte, et al.
Scientific Reports|July 9, 2024
Selection and characterization of human scFvs targeting the SARS-CoV-2 nucleocapsid protein isolated from antibody libraries of COVID-19 patientsSimonetta Lisi, Francesca Malerba, Paola Quaranta, et al.
Computational and Structural Biotechnology Journal|November 8, 2021
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cellsBarbara Storti, Paola Quaranta, Cristina Di Primio, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Virology|September 22, 2021
CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal RepeatsMichele Lai, Eyal Maori, Paola Quaranta, et al.
Cytotherapy|January 23, 2016
Human Wharton's jelly-derived mesenchymal stromal cells engineered to secrete Epstein-Barr virus interleukin-10 show enhanced immunosuppressive propertiesPaola Quaranta, Daniele Focosi, Marilena Di Iesu, et al.
Antiviral Research|April 12, 2017
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challengeNicola Clementi, Elena Criscuolo, Francesca Cappelletti, et al.
Diabetes Technology & Therapeutics|May 18, 2010
Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantationBiancamaria Longoni, Erzsebet Szilagyi, Paola Quaranta, et al.
PNAS Nexus|September 21, 2023
Severe acute respiratory syndrome coronavirus 2 infection leads to Tau pathological signature in neuronsCristina Di Primio, Paola Quaranta, Marianna Mignanelli, et al.
Journal of Medical Genetics|January 6, 2016
Gene editing of DNAH11 restores normal cilia motility in primary ciliary dyskinesiaMichele Lai, Massimo Pifferi, Andrew Bush, et al.
Viruses|May 28, 2022
Palmitoylethanolamide (PEA) Inhibits SARS-CoV-2 Entry by Interacting with S Protein and ACE-2 ReceptorRossella Fonnesu, Venkata Bala Sai Chaitanya Thunuguntla, Ganesh Kumar Veeramachaneni, et al.
Journal of Clinical Virology Plus|March 9, 2022
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibodyGiovanna Moscato, Paola Mazzetti, Ersilia Lucenteforte, et al.
Scientific Reports|July 9, 2024
Selection and characterization of human scFvs targeting the SARS-CoV-2 nucleocapsid protein isolated from antibody libraries of COVID-19 patientsSimonetta Lisi, Francesca Malerba, Paola Quaranta, et al.
Computational and Structural Biotechnology Journal|November 8, 2021
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cellsBarbara Storti, Paola Quaranta, Cristina Di Primio, et al.
Pageof 4